ARTICLE | Clinical News
Talion bepotastine besilate regulatory update
June 8, 2015 7:00 AM UTC
Mitsubishi Tanabe and Ube said Japan approved an expanded label for allergy drug Talion bepotastine besilate tablets and orally disintegrating tablets to include pediatric patients ages >=7. The selec...